← Back to headlines
New research links gene variant to greater weight loss with Wegovy
A new study suggests that individuals with a common gene variant, associated with a sweet tooth, may lose weight more effectively using the slimming drug semaglutide (Wegovy). This discovery could pave the way for personalized weight loss treatments.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
